The carcinoembryonic antigen (CEAs) family consists of a large group of evolutionarily and structurally divergent glycoproteins. The transforming growth factor-b (TGF-b) signaling pathway has been implicated in the stimulation of CEA secretion in TGF-b-sensitive colon cells, thereby possibly modulating cell adhesion and differentiation. However, the specific CEAs targeted by TGF-b signaling or underlying mechanism of the expression of CEAs has not yet been clarified. In this study, we investigated the specific CEAs targeted by the TGF-b signaling pathway. In nine human gastric cancer cell lines examined, TGF-bresponsive cell lines showed positive expression of CEAs. Expression patterns of CEA proteins correlated well with the level of CEA (CEACAM5) and CEACAM6 transcripts in these cell lines, but CEACAM1 expression was not observed in all of these cells. To investigate the role of TGF-b signaling in CEA expression, we selected two TGFb unresponsive gastric cancer cell lines; SNU638 cells that contain a mutation in the TGF-b type II receptor and SNU484 cells that express low to undetectable level of the TGF-b pathway intermediate protein, Smad3. Restoration of TGF-b signaling in these cells induced expression of the CEAs and increased activity of both CEA (CEACAM5) and CEACAM6 promoters. CEA expression was observed in the epithelium of the stomach of wild-type mice, but was markedly decreased in Smad3 null mice. These findings suggest that CEA (CEACAM5) and CEACAM6 are major target genes for Smad3-mediated TGF-b signaling.
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Introduction
The carcinoembryonic antigen (CEA) family represents one of the most divergent group of glycoproteins in mammals with respect to sequence and structure (Zimmermann, 1998; Hammarstro¨m, 1999) . The human CEA family is composed of 29 similar gene sequences. CEAs play a role in a number of normal and pathological processes, like control of granulocyte, dendritic cell, and T-cell activation (Kuijpers et al., 1992; Kammerer et al., 1998 Kammerer et al., , 2001 , regulation of differentiation, breast duct formation and angiogenesis (Huang et al., 1999; Ergun et al., 2000; Screaton et al., 2000) . In the CEA subgroup, CEA (CEACAM5) and CEACAM6 (formerly nonspecific cross-reacting antigen) are overexpressed in a wide variety of epithelial malignancies (Kim et al., 1992) , whereas CEACAM1 (formerly biliary glycoprotein) is usually downregulated (Neumaier et al., 1993) . CEAs are widely used clinically as tumor markers, specifically for the detection of colorectal carcinoma after surgical resection (Chevinsky, 1991) . Many different types of tumors (about 50% of all human tumors) show overexpression of CEAs (Chevinsky, 1991; Kim DY et al., 2000; Kim S-J et al., 2000) .
Contrary to what its name suggests, CEAs are expressed in normal adult tissue, as well as during fetal development, indicating their role in normal physiology. In vitro studies using tumor cells have demonstrated that several CEA subfamily members, notably CEACAM1, CEA (CEACAM5) and CEACAM6, can act as homophilic and heterophilic cell adhesion molecules when expressed on the tumor cell surface (Benchimol et al., 1989) . Another study suggested that CEAs play an important role in protecting the colonic mucosa from microbial invasion (Hammarstro¨m, 1999) . However, at present, there is no clear understanding of the mechanism involved in regulating CEA expression or a definitive explanation as to the function of CEAs in normal cells and in tumor cells.
Transforming growth factor-b (TGF-b) family members regulate a broad spectrum of cellular processes, including cellular growth, differentiation and apoptosis (Heldin et al., 1997) . The TGF-b family members signal through a heteromeric receptor complex consisting of both type I (TbRI) and type II (TbRII) receptor serine/threonine kinases. Activated TbRI phosphorylates the downstream signal transducers, the receptorregulated Smads (R-Smads: Smad2 and Smad3) enabling their binding to the common mediator, Smad4 (Heldin et al., 1997) . Following binding to Smad4, the complex translocates into the nucleus to activate transcription of various target genes (Massague and Chen, 2000) .
In epithelial cells, TGF-b stimulates the synthesis of extracellular matrix (ECM) adhesion molecules (Ignotz and Massague, 1987) . TGF-b inhibits the growth and promotes the differentiation of the TGF-b-responsive human colon cancer cell line Mosser and stimulates the cellular expression and secretion of the ECM adhesion molecules fibronectin, laminin and CEA (Chakrabarty et al., 1998) . TGF-b induced CEA secretion in a dosedependent manner (Chakrabarty et al., 1998) , suggesting that one of the target genes of TGF-b signaling might be CEA. However, until now, the role that TGF-b signaling plays in CEA expression has not been fully studied.
Based on these findings, we hypothesized that preservation of TGF-b signaling in human epithelial cells would be important in maintaining the expression of CEAs. To investigate the relationship between TGF-b signaling and CEA expression, we examined expression of CEAs in several gastric cancer cells.
Results

TGF-b signaling induces expression of CEAs
SNU638 human gastric cancer cells do not express a functional TbRII because of a point mutation in the polyA tract of the TbRII gene (Myeroff et al., 1995) . We have previously shown that introduction of wild-type TbRII restores TGF-b signaling and reduces tumorigenicity (Chang et al., 1997) . We used a cDNA microarray to identify genes more highly expressed in SNU638 cells engineered to stably express the wild-type TbRII gene when compared with parental SNU638 cells. The genes encoding CEAs were expressed B10-fold higher in SNU638 cells expressing wild-type TbRII than in parental SNU638 cells. Based on this, we examined expression of CEAs in nine human gastric cancer cell lines in which TGF-b responsiveness had previously been characterized (Park et al., 1994; Kang et al., 1999) . The expression of CEA proteins correlated well with TGF-b responsiveness ( Figure 1a ). All TGF-b-positive responsive cell lines (SNU16, SNU620 and SNU719) expressed high levels of CEA proteins, suggesting that TGF-b signaling may directly regulate the expression of CEAs. The expression level of CEA proteins also correlated closely with the level of CEAs in the cell lysates measured by enzyme-linked immunosorbent assay in a previous report . The anti-CEA antibody used in the current study was known to react with CEACAM1, CEA (CEACAM5) and CEA-CAM6. Therefore, we examined the expression of specific transcripts of CEA family members using the cDNA probes for CEACAM1, CEA (CEACAM5) and CEACAM6 (Figure 1b) . The CEACAM1 mRNA was not expressed in any gastric cancer cells examined. In contrast, CEA (CEACAM5) mRNA was highly expressed in SNU16 and SNU620 cells as were the mRNA transcripts of CEACAM6 in SNU16, SNU620 and SNU719 cells. SNU601 cells, which do not respond to exogenous TGF-b also showed positive CEA expression. No TbRII gene mutation was found in this cell line, but the Smad4 protein level was very low compared to other cell lines (data not shown), suggesting that low level of autocrine TGF-b signaling may contribute to the expression of CEAs. Since CEA (CEACAM5), CEACAM6 and CEACAM8 genes are highly homologous, we designed specific primers for these genes for reverse transcription (RT)-PCR. RT-PCR results were correlated well with those of northern blot analysis ( Figure 1c ). CEACAM8 transcript was not detected in any of the human gastric cancer cell lines examined (data not shown). We next examined the effects of exogenous TGF-b and endogenous TGF-b on expression of CEAs in SNU620 cells, which respond to TGFb1 and express CEAs. Pretreatment or co-treatment of SNU620 cells with IN1130, an inhibitor of activin receptor-like kinase 5 (ALK5), completely abolished the TGF-b1-induced expression of CEAs ( Figure 1d ).
Expression of wild-type TbRII restores TGF-b signaling and induces the expression of CEAs in SNU638 cells
We have previously shown that introduction of wildtype TbRII restores TGF-b signaling in SNU638 cells (Chang et al., 1997) . To confirm the previous observation, we transfected SNU638 cells with either the TGFb-responsive 3TP-Lux reporter gene construct or the SBE4-Luc reporter gene construct, which contains four Smad-binding element (SBE) sites in tandem (Chang et al., 1997) . Either a wild-type TbRII expression construct vector or a vector control was transfected along with the reporter genes. TGF-b failed to induce the TGF-b-dependent transcriptional activities of the reporter genes in the absence of TbRII, whereas transfection with TbRII enhanced the basal activities of these reporters and thus, restored TGF-b-dependent transcriptional activities of these reporters (Figures 2a and b) . This confirms that the lack of TGF-b responsiveness of SNU638 cells was mainly due to the TbRII gene mutation (Myeroff et al., 1995) . We next generated SNU638 cells stably expressing wild-type TbRII by infecting the cells with MFG-TbRII (-neo) or MFG-CAT (-neo). SNU638 drug-resistant clones expressing wild-type TbRII were selected and the expression of TbRII mRNA was confirmed by northern blot (Figure 2c ). SNU638 cells expressing TbRII (SNU638R-II-1) showed high basal levels of CEAs and TGF-b1 treatment markedly increased the expression of CEA proteins ( Figure 2d ). Northern blot analysis showed that both CEA (CEACAM5) and CEACAM6 mRNAs were increased in SNU638RII-1 cells, whereas CEACAM1 mRNA was not detected in these cells (Figure 2e (Figure 3b) . We also performed loss-of-function studies using Smad3-specific small interfering RNA (siRNA) to evaluate the specific effect of serum response factor (SRF) on TGF-b signaling. We were able to reduce endogenous Smad3 expression to 70-90% of its original level through RNA-mediated interference (RNAi) using 50-100 nM of SRF-specific siRNA (Figure 3c ). Transfection with Smad3-specific siRNA decreased basal level of CEAs, demonstrating that endocrine TGF-b signaling may be responsible for the expression of endogenous CEAs. We also examined whether knockdown of Smad3 expression abolishes the TGFb1-induced expression of CEAs in SNU620 cells. SNU620 cells were infected with a lentivirus expressing control siRNA (FG12-green fluorescent protein (GFP)) or Smad3-specific siRNA (FG12-siSmad3) and then treated with TGF-b1 for 24 h. The knockdown SNU1  SNU5  SNU16  SNU484  SNU601  SNU620  SNU638  SNU668  SNU719   SNU1  SNU5  SNU16  SNU484  SNU601  SNU620  SNU638  SNU668  SNU719   SNU1  SNU5  SNU16  SNU484  SNU601  SNU620  SNU638  SNU668 Expression of CEACAM5 and CEACAM6 by Smad3 S-U Han et al of Smad3 almost completely blocked the effect of TGF-b1 on expression of CEAs (Figure 3d ). The promoter regions of CEA (CEACAM5) and CEACAM6 are highly homologous (Figure 4a ). Sequence comparison shows multiple putative SBEs and SBE-like sequences. Therefore, to examine whether restoration of TGF-b signaling activates transcription of CEACAM6 directly, we isolated human CEACAM6 promoter fragment. The CEACAM6 5 0 -flanking region from À140 and þ 51 was fused with the coding region of the luciferase gene in the pGL3-basic reporter ( Figure 4b ). As shown in Figure 4c , CEACAM6 promoter construct showed higher basal promoter activities compared to the vector alone in SNU638-CAT cells. Promoter activities of this construct in SNU638-RII-1 cells were about 1.5-fold higher than those in SNU638-CAT cells, and TGF-b1 treatment further induced activities of this promoter. These results suggest that TGF-b signaling induces transcription of the CEACAM6 gene.
To see whether the Smad3/4 complex binds to CEACAM6 proximal promoter, we performed a chromatin crosslinking experiment. Control SNU620 cells and SRF-expressing SNU620 cells were cultured in the presence or absence of TGF-b1. These cells were then treated with formaldehyde and crosslinked chromatin 
Expression of CEACAM5 and CEACAM6 by Smad3
S-U Han et al from equivalent numbers of these cells, and were immunoprecipitated using antibodies against Smad3 and Smad4. After immunoprecipitation, enrichment of the endogenous CEACAM6 gene promoter fragment in each sample was monitored by PCR amplification using primers specific for the CEACAM6 promoter. The p15 INKb promoter was used as a positive control for the Smad3/4 complex binding to its promoter in response to TGF-b1 (Feng et al., 2002) . As shown in Figure 4d , Smad complex binding was markedly enhanced by TGF-b1 in SNU620 cells.
Introduction of Smad3 restores TGF-b signaling and induces the expression of CEA in SNU484 cells SNU484 cells express low to undetectable levels of Smad3 protein (Han et al., 2004) . Transfection of Smad3 into SNU484 cells enhanced both basal and TGF-b-dependent activities of the TGF-b-dependent reporters, p3TP-Lux and SBE-Luc, and reduces tumorigenesis (Han et al., 2004) . Western analysis revealed that high levels of Smad3 protein were detected in SNU484 cells expressing wild-type Smad3 (Figure 5a ). As shown in Figure 1a , SNU484 cells do not express CEAs. We next examined whether restoration of TGF-b signaling in SNU484 cells expressing Smad3 induces CEA expression. Both basal and TGF-b-induced expression of CEAs was markedly increased in SNU484 S3-1 cells compared to the SNU484-LPCX cells (Figure 5b) . We confirmed the presence of transcripts of CEA (CEACAM5) and CEA-CAM6 in Smad3-expressing SNU484 cells by RT-PCR (Figure 5c ).
We next examined expression of CEAs in xenograft tumors of athymic nude mice. The large tumors arising from xenografts of the SNU484-LPCX cells showed no expression of CEAs, but smaller tumors arising from SNU484 S3-1 cells showed high levels of CEA expression, which was localized principally to the intercellular membranes (Figures 6a and b) . To determine if loss of Smad3 results in the loss of CEA expression in gastric mucosa, we examined CEA expression in the stomachs of Smad3 wild-type and Smad3 null mice. Expression of CEAs was also observed in the surface mucosal epithelium of the stomach of wild-type mice and correlated well with expression of Smad3 (Yang et al., 1999) (Figure 7) . In contrast, expression of CEA was markedly decreased in the stomach of Smad3 null mice (Figure 7) , suggesting that its expression is dependent, in part, on Smad3.
Discussion
In this study, we have shown that CEA (CEACAM5) and CEACAM6 are targets of TGF-b signaling. Restoration of TGF-b signaling in TGF-b unresponsive gastric cancer cells induced expression of CEA (CEA-CAM5) and CEACAM6. Importantly, we have shown that expression of CEA was markedly decreased in the stomach of Smad3 null mice.
The role of TGF-b family members in carcinogenesis is complex. Originally named for their transforming activities in in vitro assays, TGF-bs now unequivocally demonstrate both tumor suppressor and oncogenic activities. In the current paradigm, the suppressor activities dominate in normal tissue, but during tumorigenesis, changes in TGF-b expression and cellular responses tip the balance in favor of its oncogenic activities (Kim DY et al., 2000; Kim S-J et al., 2000; Wakefield and Roberts, 2002) .
CEA is a type of adhesion molecule and loss of cell adhesion has been known as the first step of tumor invasion and metastasis. Among the nine human gastric cancer cell lines, five (SNU1, SNU5, SNU484, SNU638 and SNU668) express low to undetectable levels of CEAs and do not respond to TGF-b. Among these cells, SNU484 cells showed no expression of Smad3, whereas other cell lines had mutations in TbRII. This observation strongly suggests that intact TGF-b signaling is necessary for the expression of CEAs. Based on this information, we selected SNU484 and SNU638 cells for restoration of TGF-b signaling. SNU484 cells CEACAM6 promoter sequence from À140 to þ 51 was linked to pGL3-basic-luciferase reporter construct. (c) CEACAM6 promoterluciferase construct was transfected into SNU638-CAT and SNU638RII-1 cells, which were harvested after 24 h and assayed for luciferase activity. Transfection efficiencies were normalized by b-gal activity as described in 'Materials and methods'. Results are average of at least three experiments of three independent transfections. (d) ChIP analysis on Smad3 target genes, CEACAM6 and p15 INK4b . Crosslinked chromatin was prepared from SNU620 cells treated with TGF-b1 (5 ng/ml) for 1 and 24 h. Sonicated chromatin samples were incubated with anti-Smad3/Smad4 antibodies, and polyclonal antibody to hemagglutin epitope (HA) or IgG as a control. Immunoprecipitates were analysed by PCR. Input is 0.05% of total input chromatin. CEA, carcinoembryonic antigen; ChIP, chromatin immunoprecipitation assay; IgG, immunoglobulin G; SBE, Smad-binding element; TGF-b, transforming growth factor-b1.
expressing Smad3 and SNU638 cells expressing wildtype TbRII exhibited restoration of TGF-b signaling and reduced tumorigenicity (Chang et al., 1997; Han et al., 2004) . These cells showed positive expression of CEAs. Expression of CEAs was further induced by the treatment of exogenous TGF-b1, suggesting that TGF-b signaling regulates expression of CEAs.
Normal colonic epithelium secretes large quantities of CEAs (50-70 mg daily), and CEAs are suggested to play a role in the protection of mucosa from invasion of microorganisms (Hammarstro¨m, 1999) . However, a variety of tumors secrete high levels of CEAs. CEAs, thus, are widely used clinically as both blood and tissue tumor markers of epithelial malignancy, especially in tumors of the colon (Gold and Freedman, 1965) . This means abnormally increased expression of CEAs may have oncogenic role in carcinogenesis. Deregulated overexpression of CEA (CEACAM5) and CEACAM6 disrupts tissue architecture and increases tumorigenicity (Ordonez et al., 2000; Ilantzis et al., 2002) . It has been proposed that CEA-producing cells may be selectively spared by cellular immune defense mechanisms in tumor cell/lymphocyte interactions; soluble CEA inhibits the cytotoxic activity of immune cells against colon cancer cells in a dose-dependent manner (Kammerer and von Kleist, 1994) . However, others have shown that CEA enhanced leukocyte recruitment in angiogenic blood vessels in colon cancer, thus enabling tumor suppression (Bessa et al., 2002) . These findings indicate that another function of CEAs is the promotion of leukocyte migration into the interstitium, where they exert most of their antineoplastic actions. Since restoration of TGF-b signaling in human gastric cancer cell lines reduces tumorigenicity, it is possible that this tumor suppressor activity may be, in part, mediated through the induction of CEAs. Previous reports (Chakrabarty et al., 1998) show that TGF-b stimulates the secretion of CEA in colon cancer cells, supporting our suggestion that intact TGF-b signaling is necessary to activate CEA expression. Our observation suggests that CEAs may mediate certain TGF-b function in gastric mucosa in normal physiology.
Materials and methods
Cell lines, cell culture and reagents Human gastric cancer cell lines, SNU1, SNU5, SNU16, SNU484, SNU601, SNU620, SNU638, SNU668 and SNU719, established from gastric carcinomas of individual patients were generously supplied by Dr Jae-Gahb Park (Seoul National University College of Medicine). Cells were cultured in RPMI 1640 supplemented with 10% fetal bovine serum and maintained at 371C in an atmosphere of 5% CO 2 /95% air. IN1130 (ALK5 inhibitor) was from In2Gen (Seoul, Korea, courtesy of DK Kim). Expression of CEACAM5 and CEACAM6 by Smad3 S-U Han et al Transient transfection and luciferase assay SNU484 and SNU638 cells were seeded in six-well plates at 5 Â 10 5 cells/well as triplicates and transiently co-transfected with the 3TP-Lux reporter or SBE-Luc reporter (Zawel et al., 1998) and a b-galatosidase expression vector. Smad3 DNA was transfected into SNU484 cells and TbRII DNA into SNU638 cells using Lipofectin (Life Technologies Inc., Rockville, MD, USA), according to the manufacturer's instructions. After transfection, cells were treated with 5 ng of TGF-b1/ml for 24 h in media. All assays were performed in triplicate, and data shown are means7s.d. of three independent transfections.
Promoter construction and luciferase assay CEACAM6 promoter, described above, was cloned into the luciferase plasmid (pGL3-basic). Luciferase assays were performed as the above method. b-Gal expression vector was also co-transfected to normalize the transfection efficiencies. Transfection efficiencies were measured by b-galactosidase activity in cell extracts.
Western blot analysis
Protein extracts were heated at 951C for 5 min and were separated by 4-20% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and western blot analysis was performed with anti-CEA (A0115; Dako Co., Carpinteria, CA, USA), anti-Smad3 (LPC3; Zymed, San Francisco, CA, USA), anti-bactin (A-5441, Sigma, St Louis, MO, USA) antibodies. Anti-CEA (A0115) is known to react with CEACAM1, CEA and CEACAM6.
siRNA methods
We used the siRNA design tool (Dharmacon Inc., Lafayette, CO, USA) to identify target siRNAs. The Smad3-specific sequence was 5 0 -TCCGCATGAGCTTCGTCAA-3 0 (Smad3 nucleotides 1413-1431; GenBank accession no. NM_005902). SNU620 cells were seeded at 30% density the day before transfection. Transfections were performed by using TransIT-TKO reagent (Mirus, Madison, WI, USA), according to the manufacturer's instructions with 100 pmol of siRNA and 10 ml of transfection reagent/10 cm dish for SNU620 cells.
Chromatin immunoprecipitation assay PCR primers used for chromatin immunoprecipitation assays (ChIPs) were 5 0 -GATAGAGGATTCCTGAACAG-3 0 (sense) and 5 0 -GGTCTCTGCTGTCTTCTCTGTCCAC-3 0 (antisense) for the CEACAM6 gene promoter (À140/ þ 51) and 5 0 -GCA GGCTTCCCCGCCCTCGTGAC-3 0 (sense) and 5 0 -GTGCG GACGCGTCGCGGAGTCCTC-3 0 (antisense) for p15
INK4b
. A detailed protocol for chromatin crosslinking, immunoprecipitation and PCR was followed according to the manufacturer's instructions (Upstate USA Inc., Lake Placid, NY, USA). See additional Supplementary methods. 
